BC057079 Activators
Focad, known as focadhesin, is a protein predicted to be located in focal adhesions, with expression observed in the diencephalon lateral wall ventricular layer and midbrain ventricular layer. This suggests a role in neural development or function. Focad is orthologous to human FOCAD, and its activation mechanisms involve the interplay of various chemicals that influence focal adhesion dynamics, actin organization, and signaling pathways. The focal adhesion protein Focad plays a crucial role in cellular processes associated with adhesion and migration, particularly in the nervous system. It exhibits expression patterns in regions of the brain involved in complex processes, indicating its potential involvement in neural development and function. The activation of Focad is intricately linked to the modulation of focal adhesion dynamics, actin organization, and various signaling pathways.
Chemicals like Y-27632, a ROCK inhibitor, and Blebbistatin, a myosin II inhibitor, indirectly activate Focad by disrupting the Rho/ROCK pathway and actin dynamics, respectively. Similarly, inhibitors targeting FAK (PF-562271), Src family kinases (PP2), and Rac GTPases (EHop-016, NSC23766) impact focal adhesion turnover, influencing Focad expression and function. These chemicals provide insights into the complex regulatory network involving Focad and focal adhesion dynamics. Moreover, Focad responds to inhibitors targeting pathways like Rho/MRTF/SRF (CCG-1423) and ERK1/2 (Cytosporone B), further emphasizing its connection to broader signaling cascades. Inhibition of CHK1 (AZD7762) and PLK1 (BI-2536) influences Focad expression by disrupting cell cycle checkpoints and mitotic processes, highlighting its role in cellular events beyond focal adhesions. In conclusion, Focad emerges as a key player in neural development and function, with activation mechanisms influenced by various chemicals that modulate focal adhesion dynamics, actin organization, and signaling pathways. Understanding Focad's role contributes to our knowledge of neural processes and opens avenues for further research in neurobiology and cell biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632, a Rho-associated protein kinase (ROCK) inhibitor, indirectly activates Focad by disrupting the Rho/ROCK pathway. Inhibition of ROCK influences focal adhesion dynamics, impacting Focad expression and function. Y-27632’s role in ROCK pathway inhibition establishes an indirect activation mechanism for Focad through its impact on focal adhesion dynamics and associated cellular processes. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Blebbistatin, a myosin II inhibitor, indirectly activates Focad by influencing actin dynamics. Inhibition of myosin II affects actin organization within focal adhesions, impacting Focad expression and function. Blebbistatin’s role in myosin II inhibition establishes an indirect activation mechanism for Focad through its impact on actin dynamics and associated cellular processes. | ||||||
PF-562271 | 717907-75-0 | sc-478488 sc-478488A sc-478488B | 5 mg 10 mg 50 mg | $312.00 $474.00 $1124.00 | 3 | |
PF-562271, a focal adhesion kinase (FAK) inhibitor, indirectly activates Focad by disrupting FAK signaling. Inhibition of FAK influences focal adhesion turnover, impacting Focad expression and function. PF-562271’s role in FAK inhibition establishes an indirect activation mechanism for Focad through its impact on focal adhesion dynamics and associated cellular processes. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A, an actin polymerization inhibitor, indirectly activates Focad by disrupting actin dynamics. Inhibition of actin polymerization influences focal adhesion organization, impacting Focad expression and function. Latrunculin A’s role in actin polymerization inhibition establishes an indirect activation mechanism for Focad through its impact on actin dynamics and associated cellular processes. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2, a Src family kinase inhibitor, indirectly activates Focad by inhibiting Src family kinases. Modulating Src family kinase activities influences focal adhesion dynamics, impacting Focad expression and function. PP2’s role in kinase inhibition establishes an indirect activation mechanism for Focad through its impact on signaling cascades and associated cellular processes. | ||||||
CCG-1423 | 285986-88-1 | sc-205241 sc-205241A | 1 mg 5 mg | $30.00 $90.00 | 8 | |
CCG-1423, a Rho/MRTF/SRF pathway inhibitor, indirectly activates Focad by disrupting Rho/MRTF/SRF signaling. Inhibition of this pathway influences focal adhesion dynamics, impacting Focad expression and function. CCG-1423’s role in pathway inhibition establishes an indirect activation mechanism for Focad through its impact on focal adhesion dynamics and associated cellular processes. | ||||||
EHop-016 | 1380432-32-5 | sc-497382 | 5 mg | $80.00 | ||
EHop-016, a Rac GTPase inhibitor, indirectly activates Focad by influencing Rac-mediated signaling. Inhibition of Rac GTPase affects focal adhesion turnover, impacting Focad expression and function. EHop-016’s role in Rac GTPase inhibition establishes an indirect activation mechanism for Focad through its impact on focal adhesion dynamics and associated cellular processes. | ||||||
SMIFH2 | 340316-62-3 | sc-507273 | 5 mg | $140.00 | ||
SMIFH2, a formin inhibitor, indirectly activates Focad by disrupting actin polymerization mediated by formins. Inhibition of formins influences focal adhesion organization, impacting Focad expression and function. SMIFH2’s role in formin inhibition establishes an indirect activation mechanism for Focad through its impact on actin dynamics and associated cellular processes. | ||||||
AZD7762 | 860352-01-8 | sc-364423 | 2 mg | $107.00 | ||
AZD7762, a CHK1 inhibitor, indirectly activates Focad by disrupting cell cycle checkpoints. Inhibition of CHK1 influences focal adhesion dynamics, impacting Focad expression and function. AZD7762’s role in CHK1 inhibition establishes an indirect activation mechanism for Focad through its impact on cell cycle checkpoints and associated cellular processes. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $151.00 $525.00 | 8 | |
BI-2536, a PLK1 inhibitor, indirectly activates Focad by disrupting mitotic processes. Inhibition of PLK1 influences focal adhesion turnover, impacting Focad expression and function. BI-2536’s role in PLK1 inhibition establishes an indirect activation mechanism for Focad through its impact on mitotic processes and associated cellular processes. | ||||||